RTA certificate for Q2 FY2026 dematerialization compliance filed

Compliance View source PDF Explain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹10.49

prior close

₹10.45

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+3.5% vs market

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.1

15m

+0.5

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+4.9+1.3+3.5

Next day

+1.4+1.1+0.4

+1.0-1.7+2.7

-3.1-1.5-1.7

-3.5-0.6-2.9

-4.1-0.4-3.7

-4.6-1.4-3.2

15d

-1.5-6.0+4.5

-3.5pendingpending

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Lifesciences has submitted a certificate from its Registrar and Transfer Agent, KFin Technologies, for the quarter ended September 30, 2026, under SEBI Regulation 74(5). The certificate confirms that all securities received for dematerialization during the quarter were processed, listed on stock exchanges, and the register of members updated within required timelines. This is a routine quarterly compliance filing.

Likely market impact

Routine procedural filing, no material impact on shareholders or stock price.